Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
University Hospital of Lausanne · University of Lausanne · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
7,767
total citations
- FWCI
- 137.42
- Percentile
- 100%
- References
- 56
Citations per year
Authors
24- RSRoger StuppCorresponding
University Hospital of Lausanne, University of Lausanne
- MEMonika E. Hegi
University of Lausanne, University Hospital of Lausanne
- WMWarren Mason
Princess Margaret Cancer Centre, University of Toronto
- MJMartin J. van den Bent
Erasmus University Rotterdam
- MTMartin Taphoorn
University Medical Center Utrecht
Topics & keywords
Topics
Keywords
- Medicine
- Temozolomide
- Radiation therapy
- Concomitant
- Internal medicine
- Hazard ratio
- Clinical endpoint
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.